Quantum BioPharma Ltd. - Ordinary Shares - Class B (Sub Voting)
QNTM
Get informed when a big investor buys or sells
+ FollowMarket Cap$22.01M
Close$
$0.01
99.8% downside
Current Fair Value
99.8% downsideOvervalued by 99.8% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $22.01 Million |
|---|---|
| Enterprise Value | $19.33 Million |
| Dividend Yield | $- (-) |
| Earnings per Share | $-8.11 |
| Beta | 0.43 |
| Outstanding Shares | 6,651,217 |
Return
| Return on Equity | -314.05% |
|---|---|
| Return on Assets | -173.46% |
| Return on Invested Capital | -199.70% |
Valuation & Multiples
| P/E Ratio | -0.61 |
|---|---|
| PEG | 0.93 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | - |
| Enterprise Value to EBIT | -1.59 |
| Enterprise Value to Net Income | -1 |
| Total Debt to Enterprise | 0.05 |
| Debt to Equity | 0.12 |
Revenue Sources
No data
Insider Trades
Last Earnings Call
Report Date
August 13, 2026
EPS Estimate
$-0.41
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationNext Earnings Call
Expected Date
November 6, 2026
EPS Estimate
$-0.50
Average shareholder expectationRevenue Estimate
-
Average shareholder expectationInstitutional Put/Call Ratio
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.00000% |
|---|---|
| Total Calls | - |
| Total Puts | - |
Institutional Ownership
Holdings and activity of institutional investors.
| Ownership % | 5.66%▲ 2.36% |
|---|---|
| Total Invested | $1.23M▲ 31.01% |
| Investors Holding | 24▲ 1.00% |
ESG Score
No data
About Quantum BioPharma Ltd.
5 employees
CEO: Raza Bokhari fsd pharma inc., through its subsidiary, fv pharma inc., produces medical cannabis in canada. the company focuses on the development of indoor grown pharmaceutical grade cannabis; and research and development of various cannabinoid-based...